Are breast cancer pathology results serious? What are the pathologies of breast cancer and which is

It's not your name.

It is recommended to go to other hospitals to see, it is best to combine Chinese and Western**.

Breast cancer can be good if it is positive**, so you have to have confidence. You can take a look at what you need to know about breast cancer:

The chances of getting it wrong won't be great, but don't be discouraged, be positive!

The rate of early breast cancer** is still relatively high, and most patients can even be stored for more than 10 years. Therefore, the survival time of positive ** is still relatively long.

There is little chance that the hospital will get it wrong.

Breast cancer is one of the common malignant tumors in women, and the degree of malignancy is relatively low, which can be divided into: 1. Breast ductal cancer; 2. Invasive ductal carcinoma; 3. Lobular carcinoma; 4. Triple negative breast cancer; 5. Other rare cancers, relatively speaking, triple negative breast cancer is more serious, and it is more visible (Bai Yongli no Suke).

It is not very serious because lymphatic metastases, which are the most common route of metastasis in breast cancer, have not yet occurred.

Early, but immunohistochemistry is not too good, requiring chemotherapy and ongoing endocrine therapy**.

It's clear, you've got breast cancer. Axillary LN (1 17) indicates that 17 lymph nodes in the axillary were taken, and 1 of them had metastases. ihc：

er（+，95%）、pr（+，5%）、her－2（3+）、ki－67（+，60%）。These are the results of immunohistochemistry and are useful in guiding the use of ** drugs.

According to the above postoperative pathological results, breast cancer stage 2, that is, intermediate and early stage;

If the ER is strongly positive, it is recommended to combine endocrine ** after surgery and long-term prevention**;

HER2 is strongly positive and accompanied by lymph node cancer metastasis, if economic conditions allow, Herceptin should be combined (targeted**);

If KI-67 is moderately positive, systemic chemotherapy (CAF regimen, 6 times) must be taken after surgery, and local radiotherapy is required after chemotherapy completion;

The patient's condition is good, actively cooperates**, and the 10-year survival rate is very high.

Combination after surgery is ideal for anti-cancer

There is metastasis of cancer cells in the axillary lymph.

ER++, which can be endocrine**.

HER-2 (++) should be repeated in principle to confirm the presence of amplification, and if the risk of metastasis is increased if the amplification** is higher than that of the same disease, the addition of Herceptin is recommended.

The antibody "+" of e-CAD+ does not have a major effect on the post-administration and is mainly used to identify the pathological type of breast cancer.

The higher the positive rate of Ki-67 about 20%+, the faster the cancer cells multiply, so the lower the value, the better.